One such blocking factor in CTCL could be TGFβ (18), which is known to inhibit the induction of granzyme B, IFNγ and perforin and the release of cytotoxic granules (42). This evidence concerns the gene TGFB1 and primary cutaneous T-cell non-Hodgkin lymphoma.